相关实验视频
Updated: Jun 12, 2025

09:11
Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
6.5K
PDHX乙化通过破坏PDC组装和激活乳介导基因表达来促进瘤的进展
Zetan Jiang1,2, Nanchi Xiong1,2,3, Ronghui Yan1,2
1Department of General Surgery, Anhui Provincial Hospital, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei 230027, China.
Protein & cell
|September 23, 2024
概括
在Lys 488中对PDHX的乙化破坏了肝癌中酸盐脱酶复合体 (PDC) 的组合. 这种代谢转换为有氧糖解和基因素乳化促进瘤的进展,提供新的治疗点.
科学领域:
- 生物化学 生物化学
- 癌症生物学 癌症生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 线粒体酸盐脱酶复合体 (PDC) 失活对于癌细胞代谢从氧化酸化转换为有氧糖解来说至关重要.
- 调控PDC活动的主要重点是酸盐脱酶 (E1) 酸化,忽视了其他翻译后修改.
研究的目的:
- 为了研究酸盐脱酶复合物X (PDHX) 乙化在肝细胞癌 (HCC) 中的作用.
- 阐明PDHX乙化影响PDC组装和活性的机制.
- 探索PDHX乙化,有氧糖解和HCC进展中的表观遗传修饰之间的联系.
主要方法:
- 在HCC样本中对Lys 488的PDHX乙化进行分析.
- 生物化学试验,以评估PDHX,p300和二利基晶酶 (E2) 之间的相互作用.
- 调查PDC组装和活动.
- 评估葡萄糖代谢和基因素乳化 (H3K56乳化).
主要成果:
- PDHX Lys 488乙化在HCC中普遍存在,并通过阻碍PDHX-E2相互作用来破坏PDC组合.
- PDHX乙化抑制PDC激活,导致葡萄糖转化为乳酸 (有氧糖解) 的增加.
- 这种代谢转变与 H3K56 乳化介导的基因表达有关,促进瘤的进展.
结论:
- 在Lys 488的PDHX乙化代表了一种新的机制,可以调节HCC中的PDC组合和活性.
- PDHX Lys 488乙化和基因素乳化在推动肝细胞癌进展方面相互关联.
- PDHX乙化作为HCC的潜在生物标志物和治疗标.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
Histone Modification
13.1K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K

